Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

By | October 25, 2021
Researchers isolated single cells among individuals with and without prior infection with the SARS-CoV-2 vaccinated with BNT162b2 mRNA vaccine and compared the nature of the neutralizing antibody response against the original Wuhan virus and the subsequent variants.